Table 2.
Group results follow-up measurements and EMA–trial.
ESM-trial (n = 19) | RCT Stop (n = 8) | RCT Go (n = 4) | Cohort (n = 7) |
---|---|---|---|
No. of recurrences | 1 | 0 | 1 |
Mean number of responses (SD) | 40.9 (34.4) | 19.2 (13.9) | 48.9 (27.4) |
Positive affect | |||
B | 0.07 (0.31) | 0.25 (0.44) | −0.04 (0.12) |
R2 | 0.09 (0.13) | 0.19 (0.12) | 0.03 (0.05) |
Negative affect | |||
B | 1.06 (3.15) | −0.25 (0.49) | 0.10 (0.20) |
R2 | 0.21 (0.26) | 0.11 (0.18) | 0.09 (0.13) |
Stress | 31.79 (14.16) | 23.35 (11.65) | 25.52 (31.82) |
Main trial results (n = 121) | RCT Stop (n = 19) | RCT Go (n = 19) | Cohort (n = 83) |
Mean birthweight, in gram (SD) | 3,632.1 (474.3) | 3,369 (422.9) | 3,382.6 (463.2) |
Mean gestational age, in days (SD) | 277 (6.9) | 275 (5.5) | 275 (9.3) |
Mean BW for GA, percentile (SD) | 43.4 (33.7) | 41.6 (31.2) | 48.2 (29.8) |
Numbers are rounded. RCT, Randomized controlled trial; RCT Stop, RCT group receiving preventive cognitive therapy while tapering ADM; RCT Go, RCT group continuing ADM; ADM, antidepressant medication; ESM, experience sampling methodology; BW, birthweight; GA, gestational age; Mean BW for GA, birthweight corrected for gestational age.